Literature DB >> 18089957

Coffee, caffeine, and coronary heart disease.

Marilyn C Cornelis1, Ahmed El-Sohemy.   

Abstract

PURPOSE OF REVIEW: This review summarizes and highlights recent advances in current knowledge of the relationship between coffee and caffeine consumption and risk of coronary heart disease. Potential mechanisms and genetic modifiers of this relationship are also discussed. RECENT
FINDINGS: Studies examining the association between coffee consumption and coronary heart disease have been inconclusive. Coffee is a complex mixture of compounds that may have either beneficial or harmful effects on the cardiovascular system. Randomized controlled trials have confirmed the cholesterol-raising effect of diterpenes present in boiled coffee, which may contribute to the risk of coronary heart disease associated with unfiltered coffee consumption. A recent study examining the relationship between coffee and risk of myocardial infarction incorporated a genetic polymorphism associated with a slower rate of caffeine metabolism and provides strong evidence that caffeine also affects risk of coronary heart disease. Several studies have reported a protective effect of moderate coffee consumption, which suggests that coffee contains other compounds that may be beneficial.
SUMMARY: Diterpenes present in unfiltered coffee and caffeine each appear to increase risk of coronary heart disease. A lower risk of coronary heart disease among moderate coffee drinkers might be due to antioxidants found in coffee.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089957     DOI: 10.1097/MCO.0b013e3282f05d81

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  27 in total

1.  Comparison of 3 methods for identifying dietary patterns associated with risk of disease.

Authors:  Julia R DiBello; Peter Kraft; Stephen T McGarvey; Robert Goldberg; Hannia Campos; Ana Baylin
Journal:  Am J Epidemiol       Date:  2008-10-22       Impact factor: 4.897

Review 2.  [Stroke prevention outside the pharmacy : risk factors and lifestyle].

Authors:  J Sobesky
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

3.  Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: the impact on leptin level.

Authors:  T Imatoh; S Kamimura; M Miyazaki
Journal:  Eur J Clin Nutr       Date:  2015-03-25       Impact factor: 4.016

4.  Cardiovascular effects of long-term caffeine administration in aged rats.

Authors:  S M T El Agaty; A A Seif
Journal:  Ir J Med Sci       Date:  2014-03-18       Impact factor: 1.568

5.  Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Authors:  Natacha Vanattou-Saïfoudine; Ruth McNamara; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2010-05-02       Impact factor: 4.530

Review 6.  Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis.

Authors:  Elizabeth Mostofsky; Megan S Rice; Emily B Levitan; Murray A Mittleman
Journal:  Circ Heart Fail       Date:  2012-06-26       Impact factor: 8.790

7.  Genistein alters caffeine exposure in healthy female volunteers.

Authors:  Yao Chen; Chang-Qiong Xiao; Yi-Jing He; Bi-Lian Chen; Guo Wang; Gan Zhou; Wei Zhang; Zhi-Rong Tan; Shan Cao; Li-Ping Wang; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2010-12-14       Impact factor: 2.953

8.  Greater coffee intake in men is associated with steeper age-related increases in blood pressure.

Authors:  Paul P Giggey; Carrington R Wendell; Alan B Zonderman; Shari R Waldstein
Journal:  Am J Hypertens       Date:  2010-11-18       Impact factor: 2.689

Review 9.  Coffee Consumption and Cancer Risk: An Assessment of the Health Implications Based on Recent Knowledge.

Authors:  Ernest K J Pauwels; Duccio Volterrani
Journal:  Med Princ Pract       Date:  2021-03-24       Impact factor: 1.927

10.  Hemodynamic and hematologic profile of healthy adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine.

Authors:  Tyler M Farney; Cameron G McCarthy; Robert E Canale; Rick J Allman; Richard J Bloomer
Journal:  Nutr Metab Insights       Date:  2011-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.